Results 131 to 140 of about 51,509 (201)

Fragility fracture, atypical femoral fracture, and osteonecrosis of jaw after bisphosphonate prescription for three and five years, based on primary and secondary care data in England: nested case-control and cohort studies. [PDF]

BMJ Med
Nakafero G, McKeever T, Kukreja NS, Welsh V, Muller S, Abhishek A.   +5 more
europepmc   +1 more source

Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis. [PDF]

Pharmacoecon Open
Flanigan J, Kane S, Mirzayeh Fashami F, Zhou A, Almuallem L, Tindal M, Schauf M, Li E, Lyman GH.   +8 more
europepmc   +1 more source

Practical approach to the diagnosis, management, and treatment of pediatric patients with bone fragility: an expert opinion. [PDF]

J Endocrinol Invest
Baroncelli GI, Tessaris D, Aversa T, Bertelli E, Comberiati P, Corica D, Di Iorgi N, Faienza MF, Fintini D, Franceschi R, Grandone A, Karapurackal MA, Longhi S, Pitea M, Secco A, Trifirò G, Ubertini G, Urbano F, Vierucci F, Wasniewska M, Mora S, de Sanctis L.   +21 more
europepmc   +1 more source

Exacerbation of myasthenia gravis after zoledronic acid and denosumab: a novel clinical observation with therapeutic implications. [PDF]

BMC Neurol
Canneva S, De Giovanni A, Pagella F, Trompetto C, Grandis M, Mori L.   +5 more
europepmc   +1 more source

Comparison of Denosumab and Bisphosphonates for Sarcopenia in Postmenopausal Osteoporosis. [PDF]

J Clin Med
Yetemen SK, Hocaoglu E, Erturk E.
europepmc   +1 more source

Keeping bone resorption markers very low for 1 year after denosumab prevents bone loss at 2 years: the ReoLaus study. [PDF]

Arch Osteoporos
Liebich G, Lamy O, Pasquier J, Gonzalez-Rodriguez E.   +3 more
europepmc   +1 more source

The Effects of Bisphosphonates Used in Osteoporosis Treatment on Breast Cancer: Analysis with Integrative Bioinformatics Methods, DFT, ADMET and Molecular Docking Analysis. [PDF]

Biology (Basel)
Dogan SC, Goren K.
europepmc   +1 more source

A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review. [PDF]

Cureus
Mann RS, Chopra I, Kilic A, Saxena A, Khan B, Rupanshu R, Chavez Cavalie PS.   +6 more
europepmc   +1 more source

Comparison of the effects of denosumab and alendronate on fracture risk and bone metabolism in postmenopausal rheumatoid arthritis patients treated with oral glucocorticoids: A propensity score-matched retrospective cohort study. [PDF]

Ther Adv Musculoskelet Dis
Chen M, Lu L, Mao Y, Ji L, Xu J, Chen J, Zhu Y, Yuan J, Chen L, Yu J, Lu Q.   +10 more
europepmc   +1 more source

Trends and prescribing patterns of antiosteoporosis medicines in Chinese patients: a real-world retrospective study. [PDF]

Aging Clin Exp Res
Zhang S, Fan Y, Xue M, Jiang L, Mu C, Peng N, Yao D.   +6 more
europepmc   +1 more source